Center-Authored Papers

Filters: Author is Rosty, Christophe  [Clear All Filters]
Journal Article
Dashti GS, Buchanan DD, Jayasekara H, Ouakrim DA, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Parry S et al..  2016.  Alcohol Consumption and the Risk of Colorectal Cancer in Mismatch Repair Gene Mutation Carriers.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
Weisenberger DJ, Levine JA, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, Le Marchand L et al..  2015.  Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(3):512-9. Abstract
Levine JA, Phipps AI, Baron JA, Buchanan DD, Ahnen DJ, Cohen S, Lindor NM, Newcomb PA, Rosty C, Haile RW et al..  2015.  Clinicopathological risk factor distributions for MLH1 promoter region methylation in CIMP positive tumors.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Clendenning M, Walsh MD, Gelpi JB, Thibodeau SN, Lindor N, Potter JD, Newcomb P, Le Marchand L, Haile R, Gallinger S et al..  2013.  Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Familial cancer. 12(3):563-6. Abstract
Buchanan DD, Win AK, Walsh MD, Walters RJ, Clendenning M, Nagler BN, Pearson S-A, Macrae F, Parry S, Arnold J et al..  2013.  Family History of Colorectal Cancer in BRAF p.V600E mutated Colorectal Cancer Cases.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Rosty C, Clendenning M, Walsh MD, Eriksen SV, Southey MC, Winship IM, Macrae FA, Boussioutas A, Poplawski NK, Parry S et al..  2016.  Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.. BMJ open. 6(2):e010293. Abstract
Roberts A, Nancarrow D, Clendenning M, Buchanan DD, Jenkins MA, Duggan D, Taverna D, McKeone D, Walters R, Walsh MD et al..  2011.  Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome).. Familial cancer. 10(2):245-54. Abstract
Chau R, Dashti SG, Ouakrim DA, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Macrae FA et al..  2016.  Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.. International journal of epidemiology. 45(3):940-953. Abstract
Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ et al..  2016.  Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters RJ et al..  2010.  Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics.. PloS one. 5(7):e11636. Abstract
Jayasekara H, Reece JC, Buchanan DD, Rosty C, Dashti GS, Ouakrim DA, Winship IM, Macrae FA, Boussioutas A, Giles GG et al..  2016.  Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.. International journal of cancer. Abstract
Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, Clendenning M, Rosty C, MacInnis RJ, Giles GG et al..  2014.  Risk of Colorectal Cancer for Carriers of Mutations in MUTYH, with and without a Family History of Cancer.. Gastroenterology. Abstract
Win AK, Reece JC, Dowty JG, Buchanan DD, Clendenning M, Rosty C, Southey MC, Young JP, Cleary SP, Kim H et al..  2016.  Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.. International journal of cancer. 139(7):1557-1563. Abstract
Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP, Rosty C, Leggett B, Giles GG, Goldblatt J et al..  2013.  Risks of colorectal and other cancers after endometrial cancer for women with lynch syndrome.. Journal of the National Cancer Institute. 105(4):274-9. Abstract
Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I et al..  2012.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.. Journal of the National Cancer Institute. 104(18):1363-72. Abstract
Win AK, Buchanan DD, Rosty C, MacInnis RJ, Dowty JG, Dite GS, Giles GG, Southey MC, Young JP, Clendenning M et al..  2015.  Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.. Gut. 64(1):101-10. Abstract